These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33044887)

  • 1. Design of next-generation therapeutic IgG4 with improved manufacturability and bioanalytical characteristics.
    Chen Z; Qian Y; Song Y; Xu X; Tao L; Mussa N; Ghose S; Li ZJ
    MAbs; 2020; 12(1):1829338. PubMed ID: 33044887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region.
    Handlogten MW; Peng L; Christian EA; Xu W; Lin S; Venkat R; Dall'Acqua W; Ahuja S
    MAbs; 2020; 12(1):1779974. PubMed ID: 32633193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.
    Silva JP; Vetterlein O; Jose J; Peters S; Kirby H
    J Biol Chem; 2015 Feb; 290(9):5462-9. PubMed ID: 25568323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of molecular processing in the hinge region of therapeutic IgG4 antibodies on disposition profiles in cynomolgus monkeys.
    Stubenrauch K; Wessels U; Regula JT; Kettenberger H; Schleypen J; Kohnert U
    Drug Metab Dispos; 2010 Jan; 38(1):84-91. PubMed ID: 19850673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.
    Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL
    MAbs; 2021; 13(1):1991256. PubMed ID: 34747330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R409K mutation prevents acid-induced aggregation of human IgG4.
    Namisaki H; Saito S; Hiraishi K; Haba T; Tanaka Y; Yoshida H; Iida S; Takahashi N
    PLoS One; 2020; 15(3):e0229027. PubMed ID: 32182240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarging the repertoire of therapeutic monoclonal antibodies platforms: domesticating half molecule exchange to produce stable IgG4 and IgG1 bispecific antibodies.
    Yang X; Ambrogelly A
    Curr Opin Biotechnol; 2014 Dec; 30():225-9. PubMed ID: 25254943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo.
    Yang X; Wang F; Zhang Y; Wang L; Antonenko S; Zhang S; Zhang YW; Tabrizifard M; Ermakov G; Wiswell D; Beaumont M; Liu L; Richardson D; Shameem M; Ambrogelly A
    J Pharm Sci; 2015 Dec; 104(12):4002-4014. PubMed ID: 26308749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation.
    Gong Q; Hazen M; Marshall B; Crowell SR; Ou Q; Wong AW; Phung W; Vernes JM; Meng YG; Tejada M; Andersen D; Kelley RF
    MAbs; 2016; 8(6):1098-106. PubMed ID: 27216702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.
    Newman R; Hariharan K; Reff M; Anderson DR; Braslawsky G; Santoro D; Hanna N; Bugelski PJ; Brigham-Burke M; Crysler C; Gagnon RC; Dal Monte P; Doyle ML; Hensley PC; Reddy MP; Sweet RW; Truneh A
    Clin Immunol; 2001 Feb; 98(2):164-74. PubMed ID: 11161972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity.
    Rayner LE; Hui GK; Gor J; Heenan RK; Dalby PA; Perkins SJ
    J Biol Chem; 2014 Jul; 289(30):20740-56. PubMed ID: 24876381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory universal LC-MS/MS assay for bioanalysis of hinge region-stabilized human IgG4 mAbs in clinical studies.
    Furlong MT; Titsch C; Xu W; Jiang H; Jemal M; Zeng J
    Bioanalysis; 2014; 6(13):1747-58. PubMed ID: 24661028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective Protein A resin allows for mild sodium chloride-mediated elution of antibodies.
    Scheffel J; Hober S
    J Chromatogr A; 2021 Jan; 1637():461843. PubMed ID: 33412291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and refinement of monoclonal anti-human globulins that lack reactivity with human IgG4.
    Howie HL; Collins B; Wang X; Kapp L; Delaney M; Er LS; Lebedev JN; Zimring JC
    Transfusion; 2020 May; 60(5):1060-1068. PubMed ID: 32369193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native Mass Spectrometry, Ion Mobility, and Collision-Induced Unfolding for Conformational Characterization of IgG4 Monoclonal Antibodies.
    Hernandez-Alba O; Wagner-Rousset E; Beck A; Cianférani S
    Anal Chem; 2018 Aug; 90(15):8865-8872. PubMed ID: 29956914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate.
    Herbener P; Schönfeld K; König M; Germer M; Przyborski JM; Bernöster K; Schüttrumpf J
    PLoS One; 2018; 13(4):e0195823. PubMed ID: 29672587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
    Deveuve Q; Lajoie L; Barrault B; Thibault G
    Front Immunol; 2020; 11():168. PubMed ID: 32117299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo.
    Labrijn AF; Buijsse AO; van den Bremer ET; Verwilligen AY; Bleeker WK; Thorpe SJ; Killestein J; Polman CH; Aalberse RC; Schuurman J; van de Winkel JG; Parren PW
    Nat Biotechnol; 2009 Aug; 27(8):767-71. PubMed ID: 19620983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
    Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
    Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.